<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04751812</url>
  </required_header>
  <id_info>
    <org_study_id>2020-06178</org_study_id>
    <nct_id>NCT04751812</nct_id>
  </id_info>
  <brief_title>Venous Cannulation Pain to Guide Choice of Anesthetic Method</brief_title>
  <official_title>The Use of Venous Cannulation Pain for Evaluation of Pain Sensitivity in an Attempt to Guide Pain Therapy During and Following Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Halland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lund University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Region Halland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators have recently shown that pain associated with peripheral venous cannulation&#xD;
      can be used to predict the risk of postoperative pain, where patients grading their pain&#xD;
      associated with venous cannulation (VCP) above 2.0 VAS units had 3.4 times higher risk of&#xD;
      moderate or severe postoperative pain after laparoscopic cholecystectomy and 1.7 times higher&#xD;
      risk in a mixed group of patients and surgeries.&#xD;
&#xD;
      The aim of this study is to investigate whether pain sensitivity measurements using VCP can&#xD;
      be used to choose anesthesia treatment protocol with the aim to lower acute postoperative&#xD;
      pain in those with high risk. In patients with low risk we aim to lower the amount of opioids&#xD;
      given.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will perform a randomized controlled trial randomizing patients to&#xD;
      different treatment protocols depending on their pain associated with venous cannulation.&#xD;
      There will be two set of instructions for perioperative treatment, one for those grading pain&#xD;
      associated with venous cannulation &lt;2.0 (low-pain) and another for those grading VCP ≥2.0&#xD;
      (high-pain).&#xD;
&#xD;
      The low-pain group will be randomized to standard treatment or opioid-free anesthesia. The&#xD;
      high-pain group will be randomized to standard treatment or extra in form of additives like&#xD;
      esketamine and clonidine.&#xD;
&#xD;
      In the low-pain group the investigators aim for non-inferiority with the gain being avoiding&#xD;
      opioids. In the high-pain group the investigators aim for lower post-operative pain.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2021</start_date>
  <completion_date type="Anticipated">May 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>The participant will be blinded to allocation arm. The anesthesia nurses, the anesthesiologist and the PACU-nurse will not be blinded to the intervention. The assistant nurse performing the postoperative pain assessments will be blinded to allocation group. Once the assistant nurse has performed the assessment the PACU-nurse will decide on treatment depending on allocation and specific instructions.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>Acute, within 1.5 hours after surgery</time_frame>
    <description>Maximum pain reported on a visual analog scale (0.0-10.0 with 0.0 describing no pain and 10.0 the worst pain imaginable)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>Within 24 hours after surgery</time_frame>
    <description>Maximum pain reported on a visual analog scale (0.0-10.0 with 0.0 describing no pain and 10.0 the worst pain imaginable)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>At 3 months after surgery</time_frame>
    <description>Maximum pain reported on a visual analog scale (0.0-10.0 with 0.0 describing no pain and 10.0 the worst pain imaginable)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with moderate-severe postoperative pain</measure>
    <time_frame>Acute, 24 hours and 3 months after surgery</time_frame>
    <description>Maximum pain reported on a visual analog scale (0.0-10.0 with 0.0 describing no pain and 10.0 the worst pain imaginable). Moderate to severe pain in defined as VAS-levels ator over 4.0.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association betweens pain catastrophizing pain and VCP</measure>
    <time_frame>Preoperative measurement</time_frame>
    <description>Correlation between values on the pain catastrophizing scale and venous cannulation pain measured on a visual analog scale (0.0-10.0 with 0.0 describing no pain and 10.0 the worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association between pain catastrophizing and postoperative pain</measure>
    <time_frame>Acute, within 1.5 hours after surgery</time_frame>
    <description>Correlation between values on the pain catastrophizing scale and pain measured on a visual analog scale (0.0-10.0 with 0.0 describing no pain and 10.0 the worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association between pain catastrophizing and postoperative pain</measure>
    <time_frame>Within 24 hours after surgery</time_frame>
    <description>Correlation between values on the pain catastrophizing scale and pain measured on a visual analog scale (0.0-10.0 with 0.0 describing no pain and 10.0 the worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association between pain catastrophizing and postoperative pain</measure>
    <time_frame>At 3 months after surgery</time_frame>
    <description>Correlation between values on the pain catastrophizing scale and pain measured on a visual analog scale (0.0-10.0 with 0.0 describing no pain and 10.0 the worst pain imaginable)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">270</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Pain Prediction</condition>
  <condition>Laparoscopic Surgery</condition>
  <condition>Venous Cannulation Pain</condition>
  <condition>Anesthesia Opioid Free</condition>
  <arm_group>
    <arm_group_label>High-pain standard</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients grading pain associated with venous cannulation &gt;=2.0 allocated to standard treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High-pain extra</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients grading pain associated with venous cannulation &gt;2.0 allocated to extra treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low-pain standard</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients grading pain associated with venous cannulation to &lt;2.0 allocated to standard treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low-pain opioid-free</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient grading pain associated with venous cannualation to &lt;2.0 allocated to opioid-free anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>High-pain extra</intervention_name>
    <description>Paracetamol, Etoricoxib, Oxycodone, Ondansetron po. Betamethasone 4 mg iv.&#xD;
Anesthesia:&#xD;
As &quot;standard&quot; + bolus esketamine 0.25 mg/kg iv + Clonidine 1 µg/kg i.v.&#xD;
Postoperative pain treatment:&#xD;
At pain NRS ≥ 4 - 5 mg of oxycodone i.v. Paracetamol will be administered every 6 hours. If above is not sufficient bolus Clonidine 1 µg/kg i.v.</description>
    <arm_group_label>High-pain extra</arm_group_label>
    <other_name>More extensive pain treatment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Low-pain opioid free</intervention_name>
    <description>Paracetamol, Etoricoxib, Ondansetron p.o. Betamethasone 4 mg iv.&#xD;
Anesthesia:&#xD;
Infusion Dexmedetomidin 0.2 mikrogram/kg/h iv started 5 min before induction Induction: Esketamin 0.1mg/kg + Propofol 1.5-2 mg/kg iv + rocuronium 0.5 mg/kg iv Start of surgery: Esketamin 0.1 mg/kg iv. Maintenance of anesthesia: Sevoflurane Dexmedetomidin inf 0.2 mikrogram/kg/h Esketamin inf 0.1-0.3mg/kg/h and 0.1 mg/kg adjusted after BP and HR 30 min before end of surgery Lidocaine 1 mg/kg iv&#xD;
Postoperative pain treatment:&#xD;
• Dexmedetomidin (inf 01-0.2 µg/kg/h) 4 hours postoperative&#xD;
If pain NRS ≧3 Esketamin 0.1mg/kg iv + Lidocain 0.5 mg/kg iv (max 4 mg/kg /4 h) If pain NRS ≧3 within 30 min after treatment above is given with Esketamin + Lidocain, 2.5 mg Oxycodone iv. is given and may be repeated.</description>
    <arm_group_label>Low-pain opioid-free</arm_group_label>
    <other_name>Opioid free anesthesia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard</intervention_name>
    <description>Paracetamol, Etoricoxib, Oxycodone, Ondansetron p.o. Betamethasone 4 mg iv.&#xD;
Anesthesia:&#xD;
Target controlled infusion (TCI) with doses of propofol and remifentanil based on age, weight and height. Oxycodone 0.1 mg/kg 30 minutes before cessation of remifentanil.&#xD;
Postoperative care:&#xD;
At pain NRS ≥ 4 - 5 mg of oxycodone i.v. Paracetamol will be administered every 6 hours. If above is not sufficient bolus Clonidine 1 µg/kg i.v.</description>
    <arm_group_label>High-pain standard</arm_group_label>
    <arm_group_label>Low-pain standard</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults with an American Society of Anesthesiologists (ASA) physical status I or II,&#xD;
             undergoing elective laparoscopic procedures for non-cancer surgery at Hallands´&#xD;
             hospital.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to understand information regarding the study. Refusal to give consent.&#xD;
             Severe cardiovascular disease. AV-block II. Chronic pain (back, shoulder, knee).&#xD;
             Requirement of additional procedures during surgery, like conversion of laparoscopic&#xD;
             to open surgery, incomplete registration of study measurements.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anna KM Persson, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Region Halland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anna KM Persson, PhD, MD</last_name>
    <phone>004635-131676</phone>
    <email>anna.p.persson@regionhalland.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lars-Erik Dyrehag, PhD, MD</last_name>
    <phone>004635-131284</phone>
    <email>lars-erik.dyrehag@regionhalland.se</email>
  </overall_contact_backup>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 5, 2021</study_first_submitted>
  <study_first_submitted_qc>February 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2021</study_first_posted>
  <last_update_submitted>February 9, 2021</last_update_submitted>
  <last_update_submitted_qc>February 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Region Halland</investigator_affiliation>
    <investigator_full_name>Anna Persson</investigator_full_name>
    <investigator_title>MD, PhD, Consultant in Anaesthesia and Intensive Care Medicine</investigator_title>
  </responsible_party>
  <keyword>Postoperative pain</keyword>
  <keyword>Pain prediction</keyword>
  <keyword>VCP</keyword>
  <keyword>Venous Cannulation Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics, Opioid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

